Form 4: Bio-Techne Corp Director Roeland Nusse Sells 10,400 Shares
SEC Form 4
Roeland Nusse, a director at Bio-Techne Corp, sold 10,400 shares of common stock at a weighted average price of $76.9834 on March 7, 2024.
Summary
- On March 7, 2024, Roeland Nusse, a director of Bio-Techne Corp, sold 10,400 shares of common stock.
- The sale was executed at a weighted average price of $76.9834 per share.
- Following the transaction, Nusse directly owns 43,097 shares of Bio-Techne Corp common stock.
- Nusse also holds various stock options to purchase common stock at prices ranging from $21.84 to $128.81, with expiration dates between 2025 and 2033.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the director selling shares, which could indicate a lack of confidence in the company's near-term prospects, although it could also be for personal financial reasons.
Negatives
- A director selling shares could be perceived negatively by investors.
Risks
- Further sales by insiders could put downward pressure on the stock price.
Industry Context
Insider trading activity is always closely watched by investors as it can provide signals about a company's prospects; however, it is only one data point and should be considered alongside other information.
Stakeholder Impact
- Shareholders may react to the insider selling activity.
Key Dates
| Date | Description |
|---|---|
| 10/29/2016 | Date of grant for stock options with an exercise price of $21.84 and an expiration date of 10/28/2025. |
| 10/26/2017 | Date of grant for stock options with an exercise price of $25.3 and an expiration date of 10/27/2026. |
| 10/25/2018 | Date of grant for stock options with an exercise price of $31.26 and an expiration date of 10/26/2027. |
| 10/24/2019 | Date of grant for stock options with an exercise price of $44.96 and an expiration date of 10/25/2028. |
| 10/24/2020 | Date of grant for stock options with an exercise price of $50.41 and an expiration date of 10/24/2029. |
| 10/28/2021 | Date of grant for stock options with an exercise price of $63.92 and an expiration date of 10/29/2030. |
| 10/27/2022 | Date of grant for stock options with an exercise price of $128.81 and an expiration date of 10/28/2031. |
| 10/26/2023 | Date of grant for stock options with an exercise price of $73.94 and an expiration date of 10/27/2032. |
| 10/26/2023 | Date of grant for stock options with an exercise price of $61.51 and an expiration date of 10/26/2033. |
| 03/07/2024 | Date of the transaction where Roeland Nusse sold 10,400 shares of common stock. |
| 03/11/2024 | Date of signature for the form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.